Abstract
Background/Aim: Cortactin (CTTN) has been considered a promising molecular prognostic factor in various types of cancers. In this study, we aimed to investigate the role of CTTN in the pathogenesis of cutaneous squamous cell carcinoma (CSCC). Materials and Methods: CTTN and phospho-CTTN (p-CTTN) expression was determined in 10 healthy controls and 38 CSCC tissue samples by immunohistochemistry. The influence of CTTN on the biological behavior of CSCC cells was also investigated. Results: p-CTTN expression was significantly increased in CSCC than control samples. In contrast, no significant difference in CTTN expression was found between control and CSCC tissues. Moreover, a significant association was found between recurrence-free survival with p-CTTN expression, but not with CTTN expression. Furthermore, the proliferative, migratory, and invasive abilities of CSCC cells were significantly decreased by CTTN-siRNA transfection. Conclusion: CTTN phosphorylation is strongly associated with CSCC pathogenesis and may serve as a molecular biomarker of CSCC.
| Original language | English |
|---|---|
| Pages (from-to) | 393-400 |
| Number of pages | 8 |
| Journal | In Vivo |
| Volume | 33 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - 2019 Mar 1 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Biochemistry, Genetics and Molecular Biology(all)
- Pharmacology
Cite this
}
The pathogenic effect of cortactin tyrosine phosphorylation in cutaneous squamous cell carcinoma. / Zhu, Lianhua; Cho, Eunae; Zhao, Guohua; Roh, MiRyung; Zheng, Zhenlong.
In: In Vivo, Vol. 33, No. 2, 01.03.2019, p. 393-400.Research output: Contribution to journal › Article
TY - JOUR
T1 - The pathogenic effect of cortactin tyrosine phosphorylation in cutaneous squamous cell carcinoma
AU - Zhu, Lianhua
AU - Cho, Eunae
AU - Zhao, Guohua
AU - Roh, MiRyung
AU - Zheng, Zhenlong
PY - 2019/3/1
Y1 - 2019/3/1
N2 - Background/Aim: Cortactin (CTTN) has been considered a promising molecular prognostic factor in various types of cancers. In this study, we aimed to investigate the role of CTTN in the pathogenesis of cutaneous squamous cell carcinoma (CSCC). Materials and Methods: CTTN and phospho-CTTN (p-CTTN) expression was determined in 10 healthy controls and 38 CSCC tissue samples by immunohistochemistry. The influence of CTTN on the biological behavior of CSCC cells was also investigated. Results: p-CTTN expression was significantly increased in CSCC than control samples. In contrast, no significant difference in CTTN expression was found between control and CSCC tissues. Moreover, a significant association was found between recurrence-free survival with p-CTTN expression, but not with CTTN expression. Furthermore, the proliferative, migratory, and invasive abilities of CSCC cells were significantly decreased by CTTN-siRNA transfection. Conclusion: CTTN phosphorylation is strongly associated with CSCC pathogenesis and may serve as a molecular biomarker of CSCC.
AB - Background/Aim: Cortactin (CTTN) has been considered a promising molecular prognostic factor in various types of cancers. In this study, we aimed to investigate the role of CTTN in the pathogenesis of cutaneous squamous cell carcinoma (CSCC). Materials and Methods: CTTN and phospho-CTTN (p-CTTN) expression was determined in 10 healthy controls and 38 CSCC tissue samples by immunohistochemistry. The influence of CTTN on the biological behavior of CSCC cells was also investigated. Results: p-CTTN expression was significantly increased in CSCC than control samples. In contrast, no significant difference in CTTN expression was found between control and CSCC tissues. Moreover, a significant association was found between recurrence-free survival with p-CTTN expression, but not with CTTN expression. Furthermore, the proliferative, migratory, and invasive abilities of CSCC cells were significantly decreased by CTTN-siRNA transfection. Conclusion: CTTN phosphorylation is strongly associated with CSCC pathogenesis and may serve as a molecular biomarker of CSCC.
UR - http://www.scopus.com/inward/record.url?scp=85062172977&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85062172977&partnerID=8YFLogxK
U2 - 10.21873/invivo.11486
DO - 10.21873/invivo.11486
M3 - Article
VL - 33
SP - 393
EP - 400
JO - In Vivo
JF - In Vivo
SN - 0258-851X
IS - 2
ER -